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Neutrophil activation in vitro and in vivo in kidneys in Wegener's
granulomatosis. The mechanisms underlying glomerular capillary wall
injury in Wegener's granulomatosis (WG) are not well understood.
Anti-neutrophil cytoplasmic antibodies (ANCA), present in sera from
patients with WG, are known to stimulate respiratory burst and
degranulation of primed polymorphonuclear neutrophils (PMN) in
vitro. Experimental studies have shown that oxygen radical production
and lysosomal enzymes are important mediators of glomerular capillary
wall injury. In the present study we investigated the presence of
activated PMN and the extracellular localization of lysosomal enzymes
in 28 consecutive renal biopsies from patients with WG. The presence
of activated PMN within the renal biopsies was compared with the
capacity of ANCA, isolated from simultaneously drawn serum samples,
to activate primed PMN obtained from a normal donor. Both parame-
ters were also related to renal function. Renal biopsies were obtained
from newly diagnosed WG patients before therapy had started. Activa-
tion of PMN in the biopsies was assessed by measuring hydrogen
peroxide production in situ. The number of activated PMN in the
biopsy correlated with the extent of impairment of renal function
Proteinase 3, myeloperoxidase, and elastase, all targets of ANCA, were
localized extracellularly in renal tissue and were also found within
tubular epithelial cells. All ANCA positive samples were capable of
activating primed PMN, The amount of activation correlated with the
ANCA titer in those samples. No correlation, however, was found
between the in vitro capacity of ANCA-positive IgG fractions to
activate primed PMN and the number of activated PMN present in the
renal biopsy. We conclude that activated PMN producing toxic oxygen
metabolites and releasing lysosomal enzymes, are present in renal
biopsies from patients with WG. The amount of activated PMN present
within the kidney, and not the capacity of the corresponding ANCA to
activate PMN, correlates with renal tissue damage as assessed by
serum creatinine levels.
Wegener's granulomatosis (WG) is characterized by systemic
vasculitis with necrotizing granulomatous inflammation, in par-
ticular of the respiratory tract, and necrotizing crescentic
glomerulonephritis (NCGN) [1]. The kidneys are frequently
involved as the main target organs [2, 3]. The earliest lesions
appear as small foci consisting of fibrinoid necrosis of glomer-
ular capillary loops [4—6]. Immunofluorescence studies of
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NCGN in WG have shown absent or infrequent, non-specific
deposits of immunoglobulins (Ig) and complement along the
glomerular basement membrane (GBM), so called pauci im-
mune glomerulonephritis [7, 8]. In most forms of proliferative
glomerulonephritis an immunologically-mediated inflammatory
insult is responsible for glomerular capillary wall injury [91. At
present it is not known which mechanisms underly glomerular
capillary wall injury in WG.
Sera from patients with WG contain anti-neutrophil cytoplas-
mic antibodies (ANCA) [10—14]. ANCA in WG are directed to
proteinase 3 (PR3-ANCA) [15—17], in a minority of the cases to
myeloperoxidase (MPO-ANCA) [18—21], and incidentally to
human leukocyte elastase (HLE-ANCA) [22]. Relapses in WO
are usually preceded by a rise in ANCA titer [13, 23, 24], and
can be prevented by treatment based on changes in those titers
[25], suggesting that ANCA are involved in the pathogenesis of
NCGN in WG. Recently, it has been shown that ANCA
activate the respiratory burst and degranulation in primed
polymorphonuclear neutrophils (PMN) [26—28]. Moreover,
ANCA stimulate PMN cytotoxicity towards cultured endothe-
hal cells [29, 30]. The respiratory burst starts with the NADPH
dependent reduction of oxygen to superoxide (Or). Subse-
quently, O reacts with itself and dismutase to produce
oxygen and hydrogen peroxide (H202) [31, 321. Degranulation,
the other marker of PMN activation, leads to the release of
lysosomal enzymes like Pr3, MPO, and HLE. Pr3 and MPO are
known to localize to negatively charged structures like the
GBM and endothelial cells [33—35] and to cause glomerular
injury in the presence of its substrate H202 [36, 37]. Extracel-
lular HLE can be found in ophthalmic lesions in WG, in urine
from patients with NCGN, and serum neutrophil HLE concen-
trations parallel disease activity of WG [38—40]. HLE, also, may
localize to the GBM [41]. PR3 has not been studied in this
respect. Until now, extracellular localization of PR3, MPO, and
HLE has not been reported in renal biopsy specimens from
patients with glomerular disorders, including WG.
Activated PMN may play a pivotal role in the development of
renal lesions as seen in WG by causing direct tissue injury due
to the production of oxygen radicals and release of lysosomal
enzymes. Therefore, we investigated renal biopsies from pa-
tients with WG for the presence of activated neutrophils pro-
ducing reactive oxygen metabolites and for the extracehlular
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deposition of PR3, MPO, and HLE in relation to renal impair-
ment. As extracellular Pr3, MPO, and HLE being autoantigens
of ANCA could serve as nidus for ANCA binding, we also
studied the glomerular presence of immunoglobulins and com-
plement. Since ANCA might be held responsible for the sup-
posed PMN activation, we investigated the capacity of the
ANCA positive IgG-fractions, isolated from serum at the time
of the renal biopsy, to activate primed PMN. We related those
findings to the intrarenal presence of activated PMN and the
extent of renal impairment.
Methods
Biopsies
Diagnostic renal biopsies obtained over a period of four years
from patients with newly diagnosed Wegener's granulomatosis
(N = 25) and patients with a relapse of WG (N = 3) all positive
for ANCA were studied. The diagnosis of WG was established
by the presence of classic clinical symptoms and/or histopatho-
logical findings [19]. ANCA were directed to proteinase three in
22 patients, to myeloperoxidase in five patients, and to elastase
in one patient. Biopsies were taken before therapy had started.
Twenty biopsies were frozen and eight separate biopsies were
processed for plastic embedding. Serum creatinine (SCr) levels
(mol/liter) were measured on the day of the biopsy. Patients
were divided into three groups depending on their S levels as
indicators of renal impairment; severe (5Cr > 500 /Lmollliter),
moderate (Sr 106 to 500 mol/liter), and mild (Sr < 106
mol/liter). Tissues were processed as described below for light
microscopy, immunofluorescence and immunohistochemistry.
Frozen sections
For immunofluorescence and immunoperoxidase studies re-
nal tissue was quickly embedded in tissue-tek, snap frozen in
liquid nitrogen, and stored at —80°C. Consecutive cryostat
sections were cut at 2 or 4 tm as indicated, applied to a glass
slide, and used for immunohistochemistry.
Activated PMN
Activated PMN were assessed by histochemical demonstra-
tion of hydrogen peroxide (H202) production [42, 43]. Activated
PMN produce 02 and H202, both products of the respiratory
burst [32]. Hydrogen peroxide production by activated PMN
was demonstrated in kidney cryostat sections according to a
modified method of Briggs et al [42, 44], taking advantage of
endogenous H702 production. H202 production was detected
by the oxidation and polymerization of diaminobenzidine
(DAB) by endogenously produced H202 and peroxidase (P0).
H202 producing cells are quantitatively related to the number of
neutrophils [45]. Sections were incubated with DAB at 37°C for
30 minutes. Addition of 0.015% catalase to the incubation
medium inhibited staining completely, confirming the involve-
ment of endogenous H202 production in DAB polymerization
[44]. Sections were routinely counterstained with hematoxylin.
Total numbers of positive intraglomerular cells were counted in
each biopsy and expressed as mean cells/glomerular cross
section. In serial sections we compared H202 production and
the number of CD15 positive PMN. As negative control for
H202 production by PMN present in renal cryostat sections we
Table 1. Monoclonal antibodies used for immunohistochemistry and
immunofluorescence on frozen and plastic embedded renal biopsies
Code of
monoclonal
Recognized
antigen
Ig
(sub-)class Specificity Source
Enzymes
12.8 Proteinase 3 IgGl PMN/monocytes CLB
4.15 Myeloperoxidase IgGi PMN/monocytes CLB
NP57 Elastase IgGl PMN/monocytes Dako
Leukocytes
Leu M3 CD14 IgG2 monocytes (small
subset of PMN)
BD
Leu Ml CD15 1gM PMN (small subset
of monocytes)
BD
CD68 CD68 IgGI macrophages Dako
Abbreviations are: PMN, polymorphonuclear leukocytes; CLB, Cen-
tral Laboratory for the Blood Transfusion Service, Amsterdam, The
Netherlands; Dako, Dakopatts, Glostrup, Denmark; BD, Becton and
Dickinson, Mountain View, California, USA.
used sections of frozen gelatin embedded non-primed PMN
obtained from peripheral blood of healthy donors.
Staining procedures
For the immunodetection of PR3, MPO, and HLE we used
fixation with both ethanol and acetone buffered formalin 9%
[46]. Staining was done by a standard immunoperoxidase
method as described under leukocyte phenotyping. Cryostat
sections were examined for the presence of IgG, 1gM, IgA, and
C3 by FITC-conjugated goat anti-human antisera (Kallestad,
Chaska, Minnesota, USA). Biopsies were scored as positive or
negative with regard to deposition of immunoglobulins and
complement, and, in addition, the pattern of deposition was
determined.
Leukocyte phenotyping
A panel of monoclonal antibodies to leukocyte surface anti-
gens was used on cryostat sections for analysis of renal leuko-
cytes (Table 1). In brief, cryostat sections of snap frozen
material, cut 4 jun for immunoperoxidase (IP) and 2 pm for
immunofluorescence (IF), were dried for at least 10 minutes and
subsequently fixed in acetone. For most monoclonal antibodies
(Mabs) we used a sensitive four layer peroxidase-technique.
Briefly, sections were incubated sequentially with: (a) normal
rabbit serum 10% in phosphate buffered saline (PBS) for 20
minutes; (b) monoclonal antibody for 60 minutes; (c) rabbit
anti-mouse peroxidase labeled immunoglobulin 1:50, supple-
mented with 1% human AB serum for 15 minutes; (d) swine
anti-rabbit peroxidase labeled immunoglobulin 1:50, supple-
mented with 1% human AB serum for 15 minutes followed by
aminoethylcarbimazole (AEC) 0.2 mg/nil in 0.05 M acetate
buffer pH 4.9 containing 5% dimethylformamide plus 0.03%
hydrogen peroxide for 10 minutes. Sections were counter-
stained with hematoxylin, mounted in glycerin, and examined.
All necessary dilutions were made in PBS. Specificity of
labeling was shown by lack of staining following substitution of
the primary Mab by a non-relevant Mab directed to a pollen
antigen. Positive staining of the different types of leukocytes in
tonsil and spleen sections served as positive controls. The
median number of glomeruli available for counting was six, and
the range varied from 3 to 16 per section. Total numbers of
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labeled intraglomerular cells were counted in each biopsy and
expressed as mean cells/glomerular cross section. Cells within
crescents were included in the glomerular counts. Labeled
interstitial leukocytes were quantified by using a semiquantita-
tive method: 0 = absent, 1 = minimal, 2 = mild, 3 = moderate,
and 4 = severe. Only appropriately stained sections were
assessed.
In order to assess which cells were positive for PR3 and/or
MPO, we performed double labeling experiments with CD15 (a
granulocytic membrane antigen). Briefly, sections were incu-
bated sequentially with: (a) normal goat serum 10% in PBS for
20 minutes; (b) Mab anti-PR3 or anti-MPO for 30 minutes; (c)
FITC-conjugated goat anti-mouse IgGi 1:40 (Southern Biotech-
nology Associates, Birmingham, Alabama, USA) for 30 min-
utes; (d) anti-CD 15 for 30 minutes; (e) TRITC-labeled goat
anti-mouse 1gM for 30 minutes. The sections were mounted in
Citifluor (Fenwall laboratories, London, UK) and examined by
immunofluorescence microscopy.
Plastic sections
Renal biopsies (N = 8) were fixed in 2% paraformaldehyde in
PBS pH 7.4 for one hour at 4°C. After washing overnight in PBS
containing 6% sucrose, the biopsies were dehydrated with 100%
acetone for 30 minutes at 4°C. After dehydration the tissues
were infiltrated with glycomethacrylate (Technovit 8100 solu-
tion A, Kulzer, GmbH, Wehrheim, Germany) at 4°C for eight
hours. Following infiltration tissues were embedded in a mix-
ture of Technovit solutions A and B (30:1) according to the
manufacturers recommendation. Polymerization took place
overnight on crushed ice at 4°C. The whole procedure was done
at 4°C and all necessary incubation steps were performed on a
rotor. Two m thick sections were cut on a Reichert Jung
Supercut plastic microtome using tungsten carbide tipped hard
metal knives [47]. Sections were caught on 2% paraformalde-
hyde, affixed on glass slides, and dried.
Dried 2 m sections were post-fixed with acetone buffered
formalin 9% according to Pryzwanski, Martin and Spitznagel
[46] in order to prevent artifactual shifting of PR3, MPO, and
HLE. Since MPO and HLE shift to the nucleus in PMN after
fixation with ethanol, but have been reported to stay within the
cytoplasm after fixation with acetone buffered formalin [46],
control studies were done with PMN embedded in plastic. To
study the localization of PR3, MPO, and HLE, fixation was
followed by: (a) preincubation with normal rabbit serum 10% or
normal goat serum 10% for 30 minutes at 37°C; (b) monoclonal
incubation for two hours at 37°C in the appropriate dilutions; (c)
peroxidase conjugated rabbit anti-mouse 1:40 (Dakopatts) or
FITC-conjugated goat anti-mouse 1:40 (Dakopatts), both sup-
plemented with 1% human AB serum for 30 minutes at 37°C; (d)
blocking of the endogenous peroxidase activity when necessary
with hydrogen peroxide 0.06% in PBS at RT. The peroxidase
staining was followed by incubation with DAB 0.5 mg/ml in
PBS supplemented with immidazol 1 mglml plus 0.03% H202
for 10 minutes. Sections were counterstained with hematoxylin
or periodic acid Schiff.
The localization of PR3, MPO, or HLE in connection to PMN
was studied by double labeling with CD15 as a PMN marker.
For double labeling with CD15, sections were preincubated
with normal goat serum 10%, followed by a mixture of either
anti-PR3, anti-MPO, or anti-HLE (all 3 of the mouse IgGl
subclass), and anti-CD15 (of the mouse 1gM class) for two hours
at 37°C. This was followed by incubation with a mixture of
FITC-labeled goat anti-mouse IgGi- and TRITC-labeled goat
anti-mouse 1gM conjugates (Southern Biotechnology Associ-
ates, Birmingham, Alabama, USA), both diluted 1:40 and
supplemented with 1% normal human AB serum, for 30 minutes
at RT. All sections processed for immunofluorescence were
mounted in citifluor (Fenwall Laboratories, London, England,
UK). The median number of glomeruli available for counting
was three and the range varied from two to 13 per section.
Sera
Serum samples for the isolation of IgG were drawn from 19
out of the 20 patients with WG, of whom cryostat sections were
available, at the time of the renal biopsy. One patient was
excluded due to shortage of serum. Control sera consisted of
samples drawn from healthy volunteers. The number of periph-
eral blood leukocytes and their differentiation were also mea-
sured at the time of the renal biopsy using standard procedures.
Antineutrophil cytoplasmic antibodies
ANCA were detected in all serum samples (N =25) obtained
at the day of the renal biopsy by indirect immunofluorescence
as described previously [48]. Samples were scored as positive if
the majority of neutrophils showed positive fluorescence at a
serum dilution of at least 1:20. Antigenic specifity was deter-
mined by antigen specific ELISA's for antibodies to PR3, MPO,
and HLE [15, 19].
Isolation of IgG-ANCA
IgG was isolated by protein 0 (phast flow protein 0; Phar-
macia Fine Chemical AB, Uppsala, Sweden) chromatography.
IgG fractions were tested for contamination with lipopolysac-
charide (LPS) in the limulus amebocyte lysate (LAL) assay
according to Sturk et al [49].
Measurement of superoxide production (02)
02 production was detected by measuring the superoxide
dismutase (SOD) (S9636, Sigma Chemical Co., St. Louis,
Missouri, USA) inhibitable reduction of ferricytochrome c,
discontinuously, according to the method of Pick and Mizel [50]
with minor modifications. In short, PMN were isolated by
centrifugation on a Lymphoprep density gradient (Nycomed
Pharma AS, Oslo, Norway) from blood, anticoagulated with
0.34 M EDTA, obtained from normal donors. Contaminating
erythrocytes were lysed with ammoniumchloride. Prior to the
activation experiments PMN were treated with cytochalasin B
5 g/ml (18015, Serva, Heidelberg, Germany) for five minutes at
37°C. Priming of PMN was done with recombinant TNF-a 2
nglml (rTNF-a, Genzyme, Cambridge, Massachusetts, USA)
for 15 minutes at 37°C. Control PMN were incubated with
HBSS instead of rTNF-a. Ninety-six-well microtiter plates
(F-form, Greiner BY, Alphen aid Rijn, The Netherlands) were
incubated with fem-cytochrome C 4 mglml (C7752, Sigma
Chemical Co.) either with SOD 590 U/mI or an equal volume
HBSS and stimulus. As stimuli we used the isolated IgG
fractions of ANCA positive sera. Polyclonal rabbit anti-MPO
(Dakopatts, Glostrup, Denmark) and 0.2 /LM formyl-methionyl-
leucyl-phenylalanine (fMLP, F3506, Sigma Chemical Co.)
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Fig. 1. Precipitation of diaminobenzidine (DAB) (black staining) by endogenously produced H202 in neutrophils in cryosra: sections of renal
biopsiesfrom patients with Wegener's granulomatosis. (A) Glomerulus filled up with H202 producing PMN (x350). (B) Same glomerulus as in A;
after the addition of 0.015% catalase all H202 is scavenged and DAB precipitates are no longer visible (x350). (C) Venule within the interstitium
with H202 producing PMN (x350). (D) Same vessel as in C after the addition of 0.015% catalase (x350).
served as positive controls. HBSS and normal IgG served as
negative controls. The IgG preparations and the polyclonal
antiserum were added at a concentration of 80 g/ml. Prior to
use the IgG preparations were centrifuged in an Eppendorf
centrifuge for 15 minutes at 13,000 rpm in order to remove
possibly present aggregates. Some sera contained low levels of
LPS. These levels had no influence on the amount of 02
production in the ferricytochrome c reduction test (data not
shown). Freshly purified primed or non-primed neutrophils
were added at a concentration of 1. 106/ml, and the plates were
incubated for a total period of 60 minutes at 37°C. The plates
were scanned repeatedly at 550 nm using a thermomax mi-
croplate reader (Sopar Biochem, b.v., Nieuwegein, The Neth-
erlands). Each test was performed in duplicate and the results
were reported as the SOD inhibitable cytochrome C reduction
expressed as the difference in OD 550 units. IgG preparations of
ANCA positive sera were tested twice using two different PMN
donors. Mean values are reported.
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Table 2. Numbers of intraglomerular and interstitial H202 producing cells in serial renal cryostat sections and the capacity of ANCA to
activate PMN in patients with Wegener's granulomatosis (WG)
Renal
impairment N
ANCA
titerb
02
prod.c
Leuko'
x 109/liter
PMNd
x 109/liter
Intraglomerulara Interstitiale
H202
PMN/
CD15 H202
PMN/
CD15
Severe
Moderate
Mild
Statst
10
8
2
7(1—7)
7(1—7)
2(1—6)
NS
136 67
134 80
95 27
NS
13.8 6.1
9.2 4.0
7.8 1.6
NS
12.6 5.5
7.4 4.0
5.8 1.0
NS
5.1 4.1
1.8 1,8
0.0 0.0
S
7.4 6.4
1.8 1.1
0.8 0.0
S
1.9 0.9
0.7 0.5
0.5 0.7
NS
2.1 1.1
1.2 0.4
0.0 0.0
NS
a Patients were divided into three groups depending on the serum creatinine level (Scr): severe, >500 mo1/liter; moderate, between 106 and 500
smoI/liter; and mild, <106 mo1Jliter.
b ANCA; antineutrophil cytoplasmic antibodies; ANCA titers were expressed as reciprocal dilution steps from 0 (<16) to 7 (512). Results are
given as median and range.
Superoxide production by IgG-ANCA activated normal PMN as measured by the superoxide dismutase inhibitable cytochrome c reduction
expressed as the difference in OD 550 units. Numbers represent mean SD.d Total number of peripheral blood leukocytes and PMN as estimated on the day of the renal biopsy (x 109/liter).
e Cells were stained for H202 production and for CD15 in serial sections.
Differences between the three different groups (patients with severe, moderate, and mild renal involvement) were estimated with a
nonparametric Kruskall-Wallis test. Values <0.05 were considered significant.
Statistical analysis
Comparisons between different groups were made with a
non-parametric Kruskall-Wallis test for unpaired data and a
Mann Whitney U test when two groups were considered.
Correlations within groups for different values were assessed
with Spearman's rank correlation test. All statistical tests were
performed with a Systat statistical package for personal com-
puters. Values <0.05 were considered significant.
Results
Activated PMN in cryostat sections
H202 production as a measure of activated PMN was de-
tected by the precipitation of DAB by endogenously produced
H202 and peroxidase. Precipitation of DAB characterized by a
coarse granular staining pattern (Fig. 1 a and c), could be
inhibited by the addition of catalase to the incubation media
(Fig. 1 b and d). The specificity of the reaction for activated
PMN was tested using non-primed frozen gelatin-embedded
peripheral blood PMN obtained from a normal donor. These
PMN did not produce H202 as tested by the precipitation of
DAB. We counted the numbers of H202 producing cells and
PMN, as determined by their positive staining for CD15, within
glomeruli and interstitium in serial sections (Table 2). An
overlap in localization between H202 producing cells and PMN
was found, although not all PMN produced H202 (Table 2). The
mean number of PMN, present within the glomeruli, was larger
than that of H202 producing cells (Table 2). Patients with severe
renal involvement had significantly higher numbers of intra-
glomerular H202 producing cells than patients with moderate
and mild renal impairment (Table 2). In concordance the
number of H202 producing cells correlated significantly with
the severity of renal impairment (r = 0.537; P < 0.05).
Presence of lysosomal enzymes, immunoglobulins, and
complement in cryostat sections
The extracellular localization of Pr3, MPO, and HLE was
tested as a marker of degranulation. PR3, MPO, and HLE were
mainly present intracellularly within the glomeruli. By double
staining we found an overlap between PR3-, MPO-, and HLE-
positive cells, and cells positive for CD15 (Fig. 2 a and b). The
mean number of intraglomerular PR3 positive cells was signif-
icantly lower than that of HLE positive cells (P < 0.01; Table
3). No significant differences were noted between the number of
intraglomerular PMN and intraglomerular monocytes. PR3-,
MPO-, or HLE-positive cells could totally fill up crescents, but
also a more diffuse presence in the glomeruli was observed.
Numbers of intraglomerular MPO- and HLE-positive cells
correlated with serum creatinine levels (r =0.441; P < 0.1, r =
0.776; P < 0.05, respectively). Within the interstitium the mean
number of PMN was significantly lower than that of monocytes
(P < 0.05) and macrophages (P < 0.05; Table 3). The mean
number of PR3-positive cells was significantly lower than that
of HLE-positive cells (P < 0.05; Table 3). PR3-, MPO-, and
HLE-positive cells surrounded glomeruli and tubuli. Tubuli
were frequently positive for PR3, MPO, and HLE (Fig. 2c).
Besides localization of PR3, MPO, and HLE within intralumi-
nal casts tubular epithelial cells seemed positive as well. Since
the extracellular presence of Pr3, MPO, and HLE can serve as
target for ANCA binding we also studied the presence of
immunoglobulins and complement. By direct immunofluores-
cence IgG was never found in a granular or linear pattern along
the GBM (Table 4). However, scanty deposits of IgG were
observed in most of the biopsies. By double staining, inciden-
tally, the presence of IgG corresponded with the extracellular
presence of Pr3, MPO, and HLE (data not shown). 1gM and
Fig. 3. Immunofluorescence photographs showing the localization of elastase (HLE) in plastic embedded neutrophils. (A) Neutrophil postfixed
after sectioning and before staining with acetone buffered formalin. HLE stays within it's original localization in the cytoplasm (green fluorescence)
(xl000). (B) Neutrophil stained for HLE without post-fixation. HLE has shifted from the cytoplasm to the perinucleus (green fluorescence)
(xl000).
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Fig. 2. Im,nunofiuorescence photographs showing proteinase 3 (PR3
and myeloperoxidase (MPO) in crysostat sections of renal biopsie
from patients with Wegener's granulomatosis. (A) Crescent totally
filled up with PR3 positive cells (green fluorescence) (x200). Arrow5
indicate margins of glomerular crescent. (B) Same glomerulus as in A
showing overlap between PR3- and CD15-positive cells. CD15 is a
PMN membrane marker (red fluorescence) (x200). Arrows indicate
same glomerular margins as shown in A. (C) Tubuli positive for MPG
(green fluorescence) (x 320).
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Fig. 4. Presence of proteinase 3 (PR3), myeloperoxidase (MPO) and elastase (HLE) in plastic embedded renal tissues from patients with
Wegener's granulomatosis. (A) Extracellular presence of PR3 in a granular pattern surrounding a PMN within the interstitium (green fluorescence)
(x 1000). (B) The same cell as shown in A. The cell boundary is visualized by it's staining for CD1S, a neutrophil membrane marker (red
fluorescence) (x 1000). (C) Extracellular presence of MPO in a granular pattern within the interstitium (green fluorescence) (X500). (II)
Extracellular presence of HLE in a granular pattern within the interstitium (green fluorescence) (x500). (E) Extracellular presence of HLE along
the wall of a small vessel within the interstitium (green fluorescence) (x 1000). (F) Extracellular presence of PR3 in a linear pattern along a
glomerular capillary wall (green fluorescence) (x 1000). (G) Extracellular presence of HLE in a granular pattern within the interstitium together with
tubuli containing HLE positive casts (green fluorescence) (x320). (H) Tubules positive for PR3 as demonstrated by immunohistochemistry. PR3
is clearly present within epithelial cells as shown by the dark granular precipitates of diaminobenzidine (small arrows) (x512).
Table 3. Numbers of intraglomerular and interstitial cells positive for proteinase 3 (PR3), myeloperoxidase (MPO), and elastase (HLE) in seral
renal cryostat sections from patients with Wegener's granulomatosis (WG)
Renal
impairmenta
N of
biopsies
Intraglomerular cells"
PR3 MPO HLE
PMN
CDI5
Monocytes
CD14
Severe
Moderate
Mild
Statsc
10
8
2
5.1 3.4
3.0 2.8
1.9 0.8
NS
7.6 6.7 8.1 4.1
3.2 3.0 4.0 4.4
1.8 1.1 1.0 1.4
NS S
6.2 2.8
ND
1.3 0.4
S
5.3 3.0
ND
0.0 0.0
NS
Renal
impairment
N of
biopsies
Interstitial cells"
PR3 MPO
PMN
HLE CD15
Monocytes
CDI4
Macrophages
CD68
Severe
Moderate
Mild
Statsc
10
8
2
2.1 1.7
1.4 1.1
1.0 1.0
NS
2.2 1.1
1.7 1.1
1.0 0.0
NS
2.4 1.2 1.6 0.9
1.7 1.2 0.5 0.7
0.5 0.7 0.5 0.7
NS NS
2.4 1.1
ND
0.5 0.7
NS
3.6 0.9
ND
2.0 1.4
NS
a Patients were divided into three groups depending on their serum creatinine levels.
b Cells were stained for PR3, MPO, and HLE, CD15 (PMN), CD14 (monocytes), and CD68 (macrophages), ND = not done.
C Differences between the three different groups (patients with severe, moderate, and mild renal involement) were estimated with a
Kruskall-Wallis test. Values <0.05 were considered significant.
Table 4. Intraglomerular deposition of immunoglobulins and
complement in frozen biopsies from patients with
Wegener's granulomatosis (WG)
Renal
impairmenta
N of
biopsies IgG) 1gM"
Comple-
mentb
Severe 10 0 5 7
Moderate 8 0 2 3
Mild 2 0 0 0
Statsb NS NS S
a Patients were divided into three groups depending on their serum
creatinine levelsb Number of biopsies containing linear or granular deposits of IgG,
1gM, and complement C3
C Kruskall-Wallis test was done between the three different groups
complement C3 were present in 35 and 50% of the biopsies,
respectively, in a granular pattern along the GBM and within
Bowman's capsule (Table 4). The presence of C3 correlated
with serum creatinine levels (r = 0.584, P < 0.05).
Presence of PR3, MPO, and HLE in plastic
embedded sections
Renal tissue was embedded in plastic in order to investigate
the precise extracellular localization of PR3, MPO, and HLE.
As a control for artifactual shifting of those enzymes during
fixation, non-primed PMN from healthy donors were embedded
in plastic and stained for PR3, MPO, and HLE. After post-
fixation with acetone buffered formalin PMN stained positive
with a cytoplasmic staining pattern without shifting of MPO and
HLE towards the nucleus (Fig. 3 a and b). After staining with
monoclonals directed to PR3, MPO, and HLE four types of
staining could be distinguished: (a) intracellular staining as
shown by double labeling for PR3, MPO, or HLE and for CD15
(being a PMN membrane marker); (b) extracellular granular
staining for PR3, MPO, and HLE (Fig. 4 a, b, c and d); (c)
extracellular staining of PR3, MPO, and HLE along a linear
structure (Fig. 4 e and f); and (d) positive staining for tubular
epithelial cells (Fig. 4 g and h). Staining patterns b and c were
always found in the presence of PR3-, MPO-, and HLE-positive
cells. However, not all PR3-, MPO-, and HLE-positive cells
were accompanied by extracellular staining. Granular extracel-
lular staining for PR3 was found in all biopsies, mostly within
the interstitium. Granular extracellular staining for MPO and
HLE was detected in six out of eight biopsies. Staining along a
linear structure was observed for PR3 in three, for MPO in one,
and for HLE in six out of eight biopsies. Tubules positive for
PR3 were found in four out of eight biopsies and tubules
positive for MPO and HLE in two out of eight biopsies. Tubular
epithelial cells were also clearly positive for PR3, MPO, and
HLE (Fig. 4 g and h).
ANCA induced superoxide production
Superoxide production (02) was measured by the superox-
ide dismutase inhibitable reduction of ferricytochrome c. The
chemotactic peptide formyl-methyl-leucyl-phenylalanine and
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ble to that found by Hooke et al in crescentic glomerulonephri-
tis [51, 52]. Besides PMN, large numbers of intraglomerular and
interstitial monocytes and macrophages were present. Numbers
of HLE positive cells were higher than that of PR3 positive cells
within glomeruli and interstitium. This may be explained by the
fact that PR3 is mainly present in PMN [53, 54] and only shortly
expressed in a subset of monocytes [55, 56], whereas MPO and
HLE are expressed for a longer period in a larger subset of
monocytes [56].
The extracellular localization of lysosomal enzymes, as a
marker of PMN activation, was studied with monoclonal anti-
bodies directed to PR3, MPO, and HLE in frozen and plastic-
embedded renal biopsies. Using a plastic embedding method we
demonstrated the extracellular presence of PR3, MPO, and
HLE in two patterns: (a) a granular pattern probably due to
diffuse adherence of PR3, MPO, and HLE to extracellular
matrix proteins; and (b) binding of Pr3, MPO, and HLE to
linear, negatively charged structures as endothelial cells and
GBM. In vitro studies have shown, in agreement with our
findings, that Pr3 and MPO can stick to the surface of endothe-
hal cells [33—35]. In vivo studies in mice and rats also have
demonstrated that MPO and HLE can be present along the
GBM [36, 37, 41, 57]. Extracellular diffuse granular localization
of HLE has also been reported in ophthalmic lesions in WG [38,
40]. In our study, PR3, MPO, and HLE were additionally found
in tubular casts and within tubular epithelial cells. Although
cross reactivity between the targets of PR3-ANCA and glomer-
ular epithelium has been suggested [58], we did not observe any
binding to normal epithelial cells by our Mabs directed to the
myeloid enzymes. It also has been demonstrated that cultured
endothelial cells express Pr3 after activation with cytokines
[59]. We, however, never observed Pr3 expression within
endothelial cells of normal glomeruli. As demonstrated in mice
injected intravenously with MPO [57], Pr3, MPO, and HLE
being cationic enzymes, are probably taken up by those tubular
epithehial cells. The combination of PMN producing H202 and
the extracellular presence of Pr3, MPO, and HLE might lead to
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Fig. 6. Correlation between the ANCA titer expressed as reciprocal
dilut ions starting at 1:20 on the horizontal axis as measured in the
isolated IgG fractions and the superoxide dismutase inhibitable cyto-
chrome c reduction expressed as the difference in OD 550 units on the
vertical axis induced by these fractions (r = 0.734, P < 0.01).
0 10 20 30 40 50 60 70
Time, minutes
Fig. 5. Superoxide (02) production by PMN as measured by the
superoxide dismutase inhibitable cytochrome c reduction assay. The
horizontal axis is the time axis of O production (inminutes), the
vertical axis shows the superoxide dismutase inhibitable cytochrome c
reduction expressed as the difference in OD 550 units. The figure shows
TNF-a primed normal PMN stimulated with IgG fractions isolated from
ANCA positive sera of three representative patients (ANCA titers 40
(U), 160 (A), and >640 (•), respectively) inducing low, intermediate,
and high levels of 02 production. IgG isolated from healthy controls
induces no respiratory burst in primed PMN (•).
the heterologous polyclonal anti-myeloperoxidase used as pos-
itive controls induced 02 production by PMN, whereas buffer
did not (results not shown). Next we tested IgG fractions
isolated from ANCA positive sera of patients with WG at the
time of the renal biopsy. All ANCA-positive IgG fractions were
capable of activating TNF-a primed normal PMN as measured
by their 02 production (Table 2), whereas IgG derived from
normal healthy controls did not (Fig. 5). The amount of 02
production induced by the ANCA-samples correlated signifi-
cantly with ANCA titer in the sera tested before the IgG
isolation (r = 0.486, P < 0.05). An even stronger correlation
was found between the capacity to activate primed PMN and
the ANCA titer of the isolated IgG fractions (r = 0.734, P <
0.01; Fig. 6). Hypothesizing that ANCA could be responsible
for the intrarenal activation of PMN we related the in vitro
capacity of the ANCA samples to activate primed PMN with
the intrarenal presence of activated PMN. No correlation,
however, could be found between ANCA induced PMN acti-
vation and the number of activated PMN present within the
renal biopsies nor with the extent of impairment of renal
function.
Discussion
In the present study we found that activated neutrophils, as
assessed by their in situ H202 production, are present in renal
biopsies from patients with Wegener's granulomatosis (WG).
H202 production was detected by the precipitation of diami-
nobenzidine (DAB) by endogenously produced H202 and per-
oxidase (P0) [42—44]. Most but not all PMN produced H202.
The strong correlation that we observed between the extent of
renal impairment and the numbers of activated neutrophils
producing H202 suggests that activated PMN contribute to the
pathogenesis of renal lesions in WG. The mean number of
intraglomerular PMN found in the present study was compara-
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renal damage as seen in WG. H202 production and lysosomal
enzymes are known to play a direct role in tissue degradation
[39, 60—65]. PR3 and HLE are active elastinolytic enzymes
[15—17, 41, 66, 67], and MPO plays an important additional role
in tissue degradation by proteases [61]. Deposition of small
amounts of immunoglobulins and complement might amplify
tissue degradation by attracting more PMN.
Since we found activated PMN in the renal biopsies and
ANCA are known to activate primed PMN leading to a respi-
ratory burst and degranulation [26—28], we investigated the
PMN activating capacity of IgG preparations isolated from
ANCA positive sera drawn at the time of the renal biopsy. The
capacity of the IgG samples to activate TNF-a primed PMN
was tested by measuring the superoxide dismutase inhibitable
02 production using the ferri-cytochrome c test. All IgG
samples activated primed PMN obtained from normal donors.
The extent of activation correlated with the ANCA titer. No
correlation could be found, however, between the number of
H202 producing cells present within the renal biopsy and the in
vitro capacity of ANCA to activate PMN. Therefore other
factors besides ANCA are probably important for the in vivo
outcome. Levels of circulating TNF-a and local TNF-a produc-
tion, as shown to be present in WG [68, 69], and elevated levels
of PMN as shown in the present study might also determine the
number of activated PMN and thereby renal impairment. In
conclusion, activated neutrophils producing H202 are present
in renal biopsies from patients with WG. Their presence is
strongly associated with renal impairment. In addition to H202
production we also found extracellularly localized PR3, MPO,
and HLE as markers of PMN activation. Both H202 production
and extracellular lysosomal enzymes are known to play an
important role in tissue degradation. PMN activation might be
accomplished by ANCA as all serum specimens drawn at the
time of the biopsy induced PMN activation in vitro. Since no
direct correlation was found between the in vitro capacity to
activate PMN and the number of activated PMN present within
the renal biopsies other factors such as (local) TNF-a produc-
tion and expression of adhesion molecules probably contribute
to the attraction and intrarenal activation of neutrophils as well.
Acknowledgments
This work was supported by a grant (C88.733) from the Dutch Kidney
Foundation. Part of this work was presented in abstract form at the
Convention of the American Society of Nephrology in Baltimore, in
November 1991. We thank G. Horst for her technical assistance and V.
Fidler for statistical advice.
Reprint requests to E. Bouwer, M.D., Department of Clinical Immu-
nology, University Hospital, Oostersingel 59, 9713 EZ Groningen, The
Netherlands.
References
1. GODMAN GC, CHURO J: Wegener's granulomatosis; Pathology and
a review of the literature. Arch Pathol 58:533—553, 1954
2. FAUCI AS, HAYNE5 BF, KATZ P, WOLFF SM: Wegener's granulo-
matosis; prospective clinical and therapeutic experience with 85
patients for 21 years. Ann Intern Med 98:76—85, 1983
3. HOFFMAN GS, KERR OS, LAEVITT RY, HALLAHAN CW, LEB0vIcs
RS, Tivis WD, ROTTEM M, FAUCI AS: Wegener's granulomato-
sis: An analysis of 158 patients. Ann Intern Med 116:488—498, 1992
4. JUNCOS LI, ALEXANDER RW, MARBURY TC: Intravascular clotting
preceding crescent formation in a patient with Wegener's granulo-
matosis and rapidly progressive glomerulonephritis. Nephron 24:
17—20, 1979
5. WATANABE T, Y05HIICkwA Y, T0Y05HIMA H: Morphological and
clinical features of the kidney in Wegener's granulomatosis. A
survey of 28 autopsies in Japan. Jpn J Nephrol 23:921—930, 1981
6. WEIsS MA, CRISSMAN JD: Renal pathologic features of Wegener's
granulomatosis: A review. Semin Resp Med 10:141—148, 1989
7. STILMANT MM, BOLTON WK, STURGILL BG, SCHMITr OW,
COUSER WG: Crescentic glomerulonephritis without immune de-
posits: Clinicopathologic features, Kidney mt 15:184—195, 1979
8. RoNco P, VERROUST P, MIGNON F, KOURILSKY 0, VANHILLE PH,
MEYRIER A, MERY JPH, MOREL-MAROGER L: Immunopathological
studies of polyarteritis nodosa and Wegener's granulomatosis: A
report of 43 patients with 51 renal biopsies. Q I Med 206:212—223,
1983
9. SALANT DJ: Immunopathogenesis of crescentic glomerulonephritis
and lung purpera. Kidney mt 32:408—425, 1987
10. VAN DER WOUDE FJ, RASMUSSEN N, LoBArro 5, Wruc A, PERMIN
H, VAN Es LA, VAN DER GIESSEN M, VAN DER HEM GK, THE TH:
Auto-antibodies to neutrophils and monocytes: A new tool for
diagnosis and a marker of disease activity in Wegener's granulo-
matosis. Lancet i:425—429, 1985
11. SPECKS U, WHEATLEY CL, MCDONALD TJ, ROHRBACH MS, DER-
EMEE RA: Anticytoplasmic autoantibodies in the diagnosis and
follow-up of Wegener's granulomatosis. Mayo Clin Proc 64:28—36,
1989
12. NOLLE B, SPECKS U, LUDEMANN J, ROHRBACH MS, DEREMEE
RA, GROSS WL: Anticytoplasmic autoantibodies: Their immunodi-
agnostic value in Wegener granulomatosis. Ann Intern Med Ill:
28—40, 1989
13. COHEN TERVAERT JW, VAN DER WOUDE FJ, FAUCI AS, AMBRUS
JL, VELOSA J, KEANE WF, MEIJER S, VAN DER GIESSEN M, THE
TH, VAN DER HEM GK, KALLENBERG CGM: Association between
active Wegener's granulomatosis and anticytoplasmic antibodies.
Arch Intern Med 149:2461—2465, 1989
14. KALLENBERG CGM, MULDER AHL, COHEN TERVAERT JW: An-
tineutrophil cytoplasmic antibodies: A still-growing class of au-
toantibodies in inflammatory disorders. Am J Med 93:675—662, 1992
15. GOLDSCHMEDING R, VAN DER SCHOOT CE, TEN BOKKEL-HUININK
D, HACK CE, VAN DEN ENDE CE, KALLENBERG CGM, VON DEM
BORNE AEGER: Wegener's granulomatosis autoantibodies identify
a novel diisopropylfluorophosphate-binding protein in the lysos-
omes of normal human neutrophils. J Clin Invest 84:1577—1587,
1989
16. LUDEMANN J, UTECHT B, GROSS WL: Anti-neutrophil cytoplasm
antibodies in Wegener's granulomatosis recognize an elastinolytic
enzyme. JExp Med 171:357—362, 1990
17. N!LES JL, MCCLUSKEY RT, AHMAD MF, ARNAOUT MA: Wegen-
er's granulomatosis autoantigen is a novel neutrophil serine pro-
tease. Blood 74:1888—1893, 1989
18. FALK RJ, JENNETTE JC: Anti-neutrophil cytoplasmic antibodies
with specificity for myeloperoxidase in patients with systemic
vasculitis and idiopathic necrotizing and crescentic glomerulone-
phritis. NEnglJMed3l8:l651—l657, 1988
19. COHEN TERVAERT JW, GOLDSCHMEDING R, ELEMA JD, VAN DER
GIESSEN M, HUITEMA MG, VAN DER HEM OK, THE TH, VON DEM
BORNE AEGKR, KALLENBERG CGM: Autoantibodies against my-
eloid lysosomal enzymes in crescentic glomerulonephritis. Kidney
Jut 37:799—806, 1990
20. COHEN TERVAERT JW, GOLDSCHMEDING R, ELEMA JD, LIMBURG
PC, VAN DER GIESSEN M, HUITEMA MG, KOOLEN MI, HENE Ri,
THE TH, VAN DER HEM GK, VON DEM BORNE AEGKR, KALLEN-
BERG CGM: Association of antibodies to myeloperoxidase with
different forms of vasculitis. Art hr Rheum 33:1264—1272, 1990
21. COHEN TERVAERT JW, LIMBURO PC, ELEMA JD, HUITEMA MG,
HORST G, THE TH, KALLENBERG CGM: Detection of autoantibod-
ies to myeloid lysosomal enzymes: A useful adjunct to classification
of patients with biopsy-proven necrotizing arteritis. Am J Med
91:59—66, 1991
22. COHEN TERVAERT JW, MULDER AHL, STEGEMAN CA, ELEMA JD,
HUITEMA MG, THE TH, KALLENBERG CGM: The clinical signifi-
cance of autoantibodies to human leukocyte elastase. Ann Rheum
Dis 52:115—120, 1993
1130 Brouwer et a!: Activated neutrophils in Wegener's granulomatosis
23. JAYNE D, HEATON A, BROWNLEE A, EVANS DB, LocKwooD C:
Sequential antineutrophil cytoplasmic antibody titres in the man-
agement of systemic vasculitis. Nephrol Dial Transplant 5:309—310,
1990
24. EGNER W, CHAPEL HM: Titration of antibodies against neutrophil
cytoplasmic antigens is useful in monitoring disease activity in
systemic vasculitidis. Gun Exp Immunol 82:244—249, 1990
25. COHEN TERVAERT JW, HUITEMA MG, HENE RJ, SLUITER Wi, THE
TH, VAN DER HEM GK, KALLENBERG CGM: Prevention of re-
lapses in Wegener's granulomatosis by treatment based on antineu-
trophil cytoplasmic antibody titre. Lancet 336:709—711, 1990
26. FALK RJ, TERRELL RS, CHARLES LA, JENNETTE JC: Anti-neutro-
phil cytoplasmic autoantibodies induce neutrophils to degranulate
and produce oxygen radicals in vitro. Proc. Nail Acad Sci USA
87:4115—4119, 1990
27. CHARLES LA, CALDAS MLR, FALK RJ, TERRELL RS, JENNETTE
JC: Antibodies against granule proteins activate neutrophils in
vitro. J LeukBiol 50:539—546, 1991
28. KEOGAN MT, ESNAULT VLM, GREEN Al, LOCKWOOD CM,
BROWN DL: Activation of normal neutrophils by anti-neutrophil
cytoplasm antibodies. Clin Exp Immunol 90:228—234, 1992
29. EWERT BH, JENNETTE JC, FALK Ri: Anti-myeloperoxidase anti-
bodies stimulate neutrophils to damage endothelial cells. Kidney mt
41 :375—383, 1992
30. SAVAGE COS, POTTINGER BE, GASKIN G, PUSEY CD, PEARSON
JD: Autoantibodies developing to myeloperoxidase and proteinase
3 in systemic vasculitis stimulate neutrophil cytotoxicity toward
cultured endothelial cells. Am J Patho! 141:335—342, 1992
31. KLEBANOFF Si: Oxygen metabolism and the toxic properties of
phagocytes. Ann Intern Med 93:480—489, 1980
32. BABIOR BM: The respiratory burst of phagocytes. J Gun Invest
73:599—601, 1984
33. SAVAGE COS, POTTINGER BE, GASKIN G, PUSEY CD, PEARSON
iD: Myeloperoxidase (MPO) binds to cultured human umbilical
vein endothelial cells (HUVEC) and is recognized by autoantibod-
ies, P-ANCA, from patients with systemic vasculitis. (abstract) J
Am Soc Nephrol 2:604, 1991
34. VARGUNAM M, ADU D, TAYLOR CM, MICHAEL i, RICHARDS N,
NEUBERGER J, THOMPSON RA: Endothelium myeloperoxidase-
antimyeloperoxidase interaction in vasculitis. Nephro! Dial Trans-
plant 7: 1077—1081, 1992
35. SAVAGE COS, GASKIN G, PUSEY CD, PEARSON iD: Anti-neutrophil
cytoplasm antibodies can recognize vascular endothelial cell-bound
anti-neutrophil cytoplasm antibody-associated autoantigens. Exp
Nephrol 1:190—195, 1993
36. ioHNsoN Ri, GUGGENHEIM Si, KLEBANOFF Si, Oct-n RF, WASS
A, BAKER P, SCHULZE M, COU5ER WG: Morphologic correlates of
glomerular oxidant injury induced by the myeloperoxidase-hydro-
gen peroxide-halide system of the neutrophil. Lab Invest 5:294-301,
1988
37. JOHNSON Ri, COUSER WG, CHI EY, ADLER S, KLEBANOFF SJ:
New mechanism for glomerular injury myeloperoxidase-hydrogen
peroxide-halide system. J Gun Invest 79:1379—1387, 1987
38. TROCME SD, BARTLEY GB, CAMPBELL RI, GLEICH Gi, LEIFER-
MAN KM: Eosinophil and neutrophil degranulation in ophthalmic
lesions of Wegener's granulomatosis. Arch Ophthalmol 109:1585—
1589, 1991
39. WATANABE H, HATTORI S, KATSUDA 5, NAKANISHI I, NAGAI Y:
Human neutrophil elastase: Degradation of basement membrane
components and immunolocalization in the tissue. Biochem J
108:753—759, 1990
40. WATHEN CG, BELL D, HARRISON Di, DAWES i, DOUGLAS AC:
Neutrophil activation in Wegener's granuloma. (abstract) Am Rev
Resp Dis 137:348, 1988
41. JOHNSON Ri, COUSER WG, ALPERS CE, VISSERS M, SCHULZE M,
KLEBANOFF Si: The human neutrophil serine proteinases, elastase
and cathepsin g, can mediate glomerular injury in vivo. J Exp Med
168:1169—1174, 1988
42. BRIGGS RT, ROBINSON JM, KARNOVSKY ML, KARNOVSKY Mi:
Superoxide production by polymorphonuclear leukocytes; a cyto-
chemical approach. Histochem 84:371—378, 1986
43. KARNOVSKY MJ, ROBINSON JM, BRIGGS RT, KARNOVSKY ML:
Oxidative cytochemistry in phagocytosis: The interface between
structure and function. Histochem J 13:1—22, 1981
44. POELSTRA K, HARDONK Mi, KOUDSTAAL i, BAKKER WW: Intra-
glomerular platelet aggregation and experimental glomerulonephri-
tis. Kidney mt 37:1500—1508, 1990
45. SMITH iK, GRISHAM MB, GRANGER DN, KORTHUIS U: Free
radical defense mechanisms and neutrophil infiltration in post-
ischemic skeletal muscle. Am J Physiol 256:H789—H793, 1989
46. PRYZWANSKY KB, MARTIN LE, SPITZNAGEL JK: Immunocyto-
chemical localization of myeloperoxidase, lactoferrin, lysozyme
and neutral proteases in human monocytes and neutrophilic gran-
ulocytes. J Ret Endo Soc 24:295—3 10, 1978
47. VAN G00R H, VAN DER HORST MLC, FIDLER V, GROND i:
Glomerular macrophage modulation affects mesangial expansion in
the rat after renal ablation. Lab Invest 66:564—571, 1992
48. BROUWER E, COHEN TERVAERT iW, HORST G, HUITEMA MG, VAN
DER GIESSEN M, LIMBURG PC, KALLENBERG CGM: Predominance
of IgGl and IgG4 subclasses of anti-neutrophil cytoplasmic au-
toantibodies (ANCA) in patients with Wegener's granulomatosis
and clinically related disorders. GlinExp Immunol 83:379—386, 1991
49. STURK A, JANSSEN ME, MUYLAERT FR, JooP K, THOMAS LLM,
CATE iW TEN: Endotoxin testing in blood, in Detection of Bacterial
Endotoxins with the Limulus Amebocyte Lysate Test, edited by
LIss AR, New York, Alan Liss Publishers, 1987, p. 371
50. PICK E, MIZEL D: Rapid microassays for the measurement of
superoxide and hydrogen peroxide production by macrophages in
culture using automatic enzyme immunoassay reader. (abstract) J
Immuno! Meth 38:211, 1982
51. HOOKE DH, HANCOCK WW, GEE DC, KRAFT N, ATKINS RC:
Monoclonal antibody analysis of glomerular hypercellularity in
human glomerulonephritis. C!in Nephrol 22:163—168, 1984
52. HOOKE DH, GEE DC, ATKINS RC: Leukocyte analysis using
monoclonal antibodies in human glomerulonephritis. Kidney Int
31:964—972, 1987
53. CALAFAT i, GOLDSCHMEDING R, RINGELING PL, JANSSEN H, VAN
DER SCHOOT CE: In situ localization by double-labeling immuno-
electron microscopy of anti-neutrophil cytoplasmic antibodies in
neutrophils and monocytes. Blood 75:242—250, 1990
54. CSERNOK E, LUDEMANN i, GROSS WL, BAINTON DF: Ultrastruc-
tural localization of proteinaSe 3, the target antigen of anti-cyto-
plasmic antibodies circulating in Wegener's granulomatosis. Am J
Patho! 137:1113—1120, 1990
55. BRAUN MG, CSERNOK E, GROSS WL, MULLER-HERMELINK HK:
Proteinase 3, the target antigen of anticytoplasmic antibodies
circulating in Wegener's granulomatosis. Am JPathol 139:831—838,
1991
56. CHARLES LA, FALK Ri, JENNETFE JC: Reactivity of antineutrophil
cytoplasmic autoantibodies with mononuclear phagocytes. J Leuk
Biol5l:65—68, 1992
57. GRAHAM RC iR, KARNOVSKY Mi: Glomerular permeability; Ultra-
structural cytochemical studies using peroxidases as protein trac-
ers. JExp Med 124:1123—1133, 1966
58. ABBOTT F, JONES 5, LocKwooD CM, REES AJ: Autoantibodies to
glomerular antigens in patients with Wegener's granulomatosis.
Nephro! Dial Transplant 4:1-8, 1989
59. MAYET WJ, CSERNOK E, SZYMKOWIAK C, GROSS WL, MEYER
ZUM BOSCHENFELDE KH: Human endothelial cells express pro-
teinase 3, the target antigen of anticytoplasmic antibodies in We-
gener's granulomatosis. Blood 82:1221—1229, 1993
60. SHAH SV: Role of reactive oxygen metabolites in experimental
glomerular disease. Kidney mt 35:1093—1106, 1989
61. WEISs Si: Tissue destruction by neutrophils. N EngI J Med
320:365—376, 1989
62. SHAH SV, BARICOS WH, BA5cI A: Degradation of human glomer-
ular basement membrane by stimulated neutrophils. J Gun Invest
79:25—31, 1987
63. HENSON PM, JOHNSTON RB iR: Tissue injury in inflammation;
oxidants, proteinases, and cationic proteins. J Clin Invest 79:669—
674, 1987
64. BARICOS WH, SHAH SV: Proteolytic enzymes as mediators of
glomerular injury. Kidney Int 40:161—173, 1991
Brouwer et al: Activated neutrophils in Wegener's granulomatosis 1131
65. WESTLIN WF, GIMBRONE MA JR: Neutrophil-mediated damage to
human vascular endothelium: Role of cytokine activation. Am J
Pathol 142:117—128, 1993
66. KAO RC, WEHNER NO, SKUBITZ KM, Gi.&v BH, HOIDAL JR
Proteinase 3; A distinct human polymorphonuclear leukocyte pro-
teinase that produces emphysema in hamsters. J Cliii Invest 82:
1963—1973, 1988
67. RAO NV, WEHNER NO, MARSHALL BC, GL&Y WR, Giv BH,
HOIDAL JR: Characterization of proteinase 3 (PR-3), a neutrophil
serine proteinase. Structural and functional properties. JBiol Chem
266:9540—9548, 1991
68. DEGUCHI Y, SHIBATA N, KIsHIMOTO S: Enhanced expression of
the tumour necrosis factor/cachectin gene in peripheral blood
mononuclear cells from patients with systemic vasculitis. Clin Exp
Immunol 81:311—314, 1990
69. NORONHA I, KRUGER C, ANDRASSY K, RITZ E, WALDHERR R: In
situ production of TNF-a, IL-1/3, and IL-2R in ANCA-positive
glomerulonephritis. Kidney lit 43:682—692, 1993
